Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McNeil Imodium Advanced loperamide/simethicone combo tablets debuting later this year.

This article was originally published in The Tan Sheet

Executive Summary

McNEIL IMODIUM ADVANCED LOPERAMIDE/SIMETHICONE COMBINATION product will be introduced by the company later this year as the first OTC remedy "to offer more complete relief" from both diarrhea and gas. An NDA for the product was approved by FDA June 26. Imodium Advanced will join the company's loperamide-only Imodium A-D, which is the leading anti-diarrheal on the market, according to J&J's McNeil Consumer Products.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087250

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel